You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cell therapy

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cytokine Release Syndrome Trial (CTO1681 10 µg, CTO1681 20 µg, CTO1681 30 µg)

Not yet recruiting
  • Cytokine Release Syndrome
  • CTO1681 10 μg
  • +2 more
  • (no location specified)
Jun 6, 2023

Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Cytokine Induced Memory-like Natural Killer Cells
  • Interleukin-2
  • Boston, Massachusetts
  • +1 more
Nov 14, 2023

CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study

Not yet recruiting
  • Lymphoma
  • Chimeric Antigen Receptor
  • (no location specified)
Oct 24, 2023

Neuroendocrine Tumor (NET), Colorectal Cancer (CRC) Trial (CHM-2101 CAR-T cells)

Not yet recruiting
  • Neuroendocrine Tumor (NET)
  • Colorectal Cancer (CRC)
  • CHM-2101 CAR-T cells
  • (no location specified)
Sep 20, 2023

HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell (DC1) Vaccine, Trastuzumab, Pepinemab)

Recruiting
  • HER2-positive Breast Cancer
  • Dendritic Cell (DC1) Vaccine
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 28, 2022

Pancreatic Cancer Trial in Shanghai (Stereotactic body radiation therapy plus vNKT cell adoptive therapy)

Recruiting
  • Pancreatic Cancer
  • Stereotactic body radiation therapy plus vNKT cell adoptive therapy
  • Shanghai, China
    Changhai Hospital affiliated to Naval Medical University
Mar 13, 2023

Diabetic Foot, Diabetic Foot Ulcer, Diabetic Foot Ulcer Neuropathic Trial in Jerusalem (hOMSC200, Placebo)

Recruiting
  • Diabetic Foot
  • +2 more
  • hOMSC200
  • Placebo
  • Jerusalem, Israel
    Shaare Zedek Medical Center
Aug 15, 2023

Lymphomas, B-cell Lymphomas Trial in Houston (JV-213, Leukapheresis)

Not yet recruiting
  • Lymphomas
  • B-cell Lymphomas
  • Houston, Texas
    The University of Texas M D Anderson Cancer Center
Mar 6, 2023

Primary Mediastinal Large B-cell Lymphoma (PMBCL), Primary Mediastinal Large B Cell Lymphoma, Primary Mediastinal Large B-Cell

Not yet recruiting
  • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
  • +5 more
  • Boston, Massachusetts
  • +1 more
Jun 28, 2023

Leukemia, Lymphoma, Cardiotoxicity Trial in Philadelphia

Completed
  • Leukemia
  • +4 more
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Jan 19, 2023

    Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

    Not yet recruiting
    • Multiple Sclerosis
    • +2 more
    • KYV-101 anti-CD19 CAR-T cell therapy
    • Standard lymphodepletion regimen
    • Palo Alto, California
      Stanford Multiple Sclerosis Center
    Nov 13, 2023

    Muscle Stem Cell Quality in Atrophy

    Not yet recruiting
    • Muscle Weakness
    • +5 more
    • In vitro analyse
    • (no location specified)
    Oct 5, 2023

    Hematologic Malignancy, Large B-cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Los Angeles (autologous hematopoietic stem

    Not yet recruiting
    • Hematologic Malignancy
    • +5 more
    • autologous hematopoietic stem cells added to planned CAR T
    • Los Angeles, California
      Cedars-Sinai Medical Center
    May 31, 2023

    Measures (PROMs) in Adoptive Cell Therapy (ACT) Setting

    Not yet recruiting
    • Cancer
      • (no location specified)
      Feb 7, 2023

      Recurrent DLBCL, Refractory DLBCL Trial in Duarte (procedure, biological, radiation)

      Not yet recruiting
      • Recurrent Diffuse Large B-Cell Lymphoma
      • Refractory Diffuse Large B-Cell Lymphoma
      • Biospecimen Collection
      • +6 more
      • Duarte, California
        City of Hope Medical Center
      Mar 24, 2023

      Relapsed/Refractory Large B Cell Lymphoma Trial (biological, drug, genetic)

      Not yet recruiting
      • Relapsed/Refractory Large B Cell Lymphoma
      • ALLO-647
      • +3 more
      • (no location specified)
      Feb 6, 2023

      Multiple Myeloma Trial in United States (Talquetamab)

      Recruiting
      • Multiple Myeloma
      • Basking Ridge, New Jersey
      • +6 more
      Sep 27, 2023

      Multiple Myeloma, New Diagnosis Tumor Trial in Hangzhou (BCMA CAR-T cells)

      Recruiting
      • Multiple Myeloma
      • New Diagnosis Tumor
      • BCMA CAR-T cells
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital, College of Medicine, Zhejiang Uni
      Jan 31, 2023

      Diffuse Large B-Cell Lymphoma Patients Treated With CAR-T Cell

      Not yet recruiting
      • Diffuse Large B Cell Lymphoma
      • Gut microbiome analysis
      • Bologna, Italy
        Institute Of Hematology "Seràgnoli"
      Feb 10, 2023

      Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T)

      Recruiting
      • Multiple Myeloma
      • anti-BCMA CAR-T
      • Tianjin, Tianjin, China
        Institute of Hematology and Blood Diseases Hospital Chinese Acad
      May 4, 2023

      Idiopathic Pulmonary Fibrosis Trial in Beijing, Shanghai (REGEND001, Placebo)

      Recruiting
      • Idiopathic Pulmonary Fibrosis
      • REGEND001
      • Placebo
      • Beijing, Beijing, China
      • +2 more
      Oct 7, 2023

      Chronic Atrophic Gastritis Trial in Jinan (Mononuclear cells, Weifuchun+Hydrotalcite/L-Glutamine and Sodium Gualenate Granules)

      Not yet recruiting
      • Chronic Atrophic Gastritis
      • Mononuclear cells
      • Weifuchun+Hydrotalcite/L-Glutamine and Sodium Gualenate Granules
      • Jinan, Shandong, China
        Shandong Provincial Hospital
      Mar 29, 2023

      A Long-Term Follow-Up Study of Participants Exposed to REACT

      Not yet recruiting
      • Diabetic Kidney Disease
      • Chronic Kidney Diseases
      • Renal Autologous Cell Therapy (REACT)
      • (no location specified)
      Jun 15, 2023

      Brain Gliomas Trial in Suzhou (Allogenic B7H3 CAR-?dT cell)

      Recruiting
      • Brain Gliomas
      • Allogenic B7H3 CAR-γδT cell
      • Suzhou, Jiangsu, China
        Dushu Lake Hospital Affiliated to Soochow University
      Aug 25, 2023

      Premature Ovarian Failure Trial in Ulaanbaatar (stem cell therapy)

      Not yet recruiting
      • Premature Ovarian Failure
      • stem cell therapy
      • Ulaanbaatar, Mongolia
        Mongolian National University of Medical Science
      Nov 13, 2023